ECSP088516A - Procedimiento graduable para la preparacion de un 42-ester de rapamicina a partir de un boronato de 42-ester de rapamicina - Google Patents

Procedimiento graduable para la preparacion de un 42-ester de rapamicina a partir de un boronato de 42-ester de rapamicina

Info

Publication number
ECSP088516A
ECSP088516A EC2008008516A ECSP088516A ECSP088516A EC SP088516 A ECSP088516 A EC SP088516A EC 2008008516 A EC2008008516 A EC 2008008516A EC SP088516 A ECSP088516 A EC SP088516A EC SP088516 A ECSP088516 A EC SP088516A
Authority
EC
Ecuador
Prior art keywords
rapamycin
ester
boronate
preparation
procedure
Prior art date
Application number
EC2008008516A
Other languages
English (en)
Inventor
Anthony Scott Pilcher
Adam P Michaud
Chunhao Zhang
Clifford William Coughlin
James S Farina
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37813522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP088516(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP088516A publication Critical patent/ECSP088516A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se provee un procedimiento graduable para la preparación de un 42-éster de rapamicina mediante la reacción de un boronato de 42-éster de rapamicina con un diol y la purificación de 42-éster de rapamicina crudo por recristalización y tratamiento con un diol; se provee también un método para aislar y purificar un boronato de 42-éster de rapamicina de soluciones madre que comprenden acetona y contaminantes de rapamicina.
EC2008008516A 2005-12-07 2008-06-09 Procedimiento graduable para la preparacion de un 42-ester de rapamicina a partir de un boronato de 42-ester de rapamicina ECSP088516A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74814305P 2005-12-07 2005-12-07

Publications (1)

Publication Number Publication Date
ECSP088516A true ECSP088516A (es) 2008-07-30

Family

ID=37813522

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008516A ECSP088516A (es) 2005-12-07 2008-06-09 Procedimiento graduable para la preparacion de un 42-ester de rapamicina a partir de un boronato de 42-ester de rapamicina

Country Status (18)

Country Link
US (1) US7622578B2 (es)
EP (1) EP1957501A2 (es)
JP (1) JP2009518412A (es)
KR (1) KR20080077619A (es)
CN (1) CN101321770A (es)
AR (1) AR058284A1 (es)
AU (1) AU2006322024A1 (es)
BR (1) BRPI0619578A2 (es)
CA (1) CA2630645A1 (es)
CR (1) CR9986A (es)
EC (1) ECSP088516A (es)
GT (1) GT200800087A (es)
IL (1) IL191550A0 (es)
NO (1) NO20082375L (es)
PE (1) PE20070748A1 (es)
RU (2) RU2008120670A (es)
TW (1) TW200804399A (es)
WO (1) WO2007067560A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040693A1 (es) 2002-07-30 2005-04-13 Wyeth Corp Formulaciones parenterales
US20070142422A1 (en) * 2005-12-20 2007-06-21 Wyeth Control of CCI-779 dosage form stability through control of drug substance impurities
TW200824713A (en) * 2006-10-18 2008-06-16 Wyeth Corp Processes for the synthesis of individual isomers of mono-PEG CCI-779
CN102020661B (zh) * 2011-01-07 2013-02-13 天津市炜杰科技有限公司 一种驮瑞塞尔合成方法
WO2012131019A1 (en) * 2011-04-01 2012-10-04 Sandoz Ag Regioselective acylation of rapamycin at the c-42 position
US9446977B2 (en) 2012-12-10 2016-09-20 Corning Incorporated Method and system for making a glass article with uniform mold temperature
GB202415232D0 (en) 2024-10-16 2024-11-27 Nacamed As Composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358909A (en) * 1991-02-27 1994-10-25 Nippon Steel Corporation Method of manufacturing field-emitter
US5358908A (en) * 1992-02-14 1994-10-25 Micron Technology, Inc. Method of creating sharp points and other features on the surface of a semiconductor substrate
US5385909A (en) 1993-11-22 1995-01-31 American Home Products Corporation Heterocyclic esters of rapamycin
US5385908A (en) 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US6277983B1 (en) * 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
ATE411321T1 (de) * 2000-09-19 2008-10-15 Wyeth Corp Wasserlösliche rapamycin-ester
JP4227649B2 (ja) 2003-08-07 2009-02-18 ワイス Ｃｃｉ−７７９の位置選択的合成
UA84881C2 (ru) * 2003-09-03 2008-12-10 Уайт Аморфный 42-эфир рапамицина и 3-гидрокси-2-(гидроксиметил)-2-метилпропионовой кислоты и фармацевтическая композиция, содержащая его
PL1735321T3 (pl) * 2004-04-14 2009-04-30 Wyeth Corp Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała
MXPA06011883A (es) 2004-04-14 2006-12-14 Wyeth Corp 42-ester de prolina-rapamicina con acido 2,2-bis(hidroximetil)propionico y sintesis enzimatica de dos etapas de 42-ester de prolina-rapamicina con acido 2,2-bis(hidroximetil)propionico y 42-ester de rapamicina con acido 2,2-bis(hidroximetil)propionic
JP4224115B2 (ja) * 2004-04-14 2009-02-12 ワイス ラパマイシン４２−エステル誘導体の位置特異的合成
CA2577011A1 (en) * 2004-08-10 2006-04-13 Wyeth Cci-779 derivatives and methods of making same
RU2007119585A (ru) * 2004-12-20 2009-01-27 Вайет (Us) Производные рапамицина и их применение при лечении неврологических заболеваний
NZ574663A (en) * 2004-12-20 2010-05-28 Wyeth Corp Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
CA2595766A1 (en) * 2005-02-09 2006-08-17 Wyeth Cci-779 polymorph and use thereof
MX2007010715A (es) * 2005-03-02 2007-10-12 Wyeth Corp Recuperacion de cc-779 a partir de soluciones madre.
CA2602010A1 (en) * 2005-03-07 2006-09-14 Wyeth Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin

Also Published As

Publication number Publication date
NO20082375L (no) 2008-09-04
TW200804399A (en) 2008-01-16
WO2007067560A2 (en) 2007-06-14
JP2009518412A (ja) 2009-05-07
US20070129541A1 (en) 2007-06-07
EP1957501A2 (en) 2008-08-20
US7622578B2 (en) 2009-11-24
RU2008120670A (ru) 2010-01-20
WO2007067560A3 (en) 2007-08-02
AU2006322024A1 (en) 2007-06-14
KR20080077619A (ko) 2008-08-25
GT200800087A (es) 2008-10-06
CN101321770A (zh) 2008-12-10
AR058284A1 (es) 2008-01-30
BRPI0619578A2 (pt) 2011-10-04
PE20070748A1 (es) 2007-08-08
RU2008142554A (ru) 2010-05-10
IL191550A0 (en) 2008-12-29
CR9986A (es) 2008-08-21
CA2630645A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
ECSP088516A (es) Procedimiento graduable para la preparacion de un 42-ester de rapamicina a partir de un boronato de 42-ester de rapamicina
ECSP078060A (es) 2,4-diamino-pirimidinas como inhibidores de aurora
BRPI0812602A2 (pt) "método para a produção de um ou mais álcoois c2-c4, método para a produção de um álcool cn+m, método de purificação de um ou mais álcoois, método para a produção de um álcool purificado e aparelho para produzir um álcool purificado"
BRPI0719367B8 (pt) processo para a preparação de nebivolol, seus intermediários e usos
ECSP13012420A (es) Derivados de tetrahidro-pirido-pirimidina
BRPI0513043A (pt) processo para a produção de ácido (met) acrìlico, dispositivo para a produção de ácido acrìlico, seus usos na produção de ácido (met) acrìlico, ácido (met) acrìlico, polìmeros absorvedores de água, e fibras, folhas, espumas e compósitos
BR0314133A (pt) Métodos para a preparação, isolamento e purificação de epotilona b e raios x de estruturas de cristal de epotilona b
CU23757B7 (es) Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios
BR112012006176A2 (pt) inibidores macrocíclicos de jak
CR11463A (es) Compuestos de piridilmetil-sulfonamida
BRPI0606170A2 (pt) purificação diastereomérica de rosuvastatina
FR2938777B1 (fr) Catalyseur en coquille, procede de preparation et utilisation de ce catalyseur.
CL2007000773A1 (es) Uso de compuestos derivados de diazepina condensada para el tratamiento de un desorden cognitivo como add o adhd;o su uso para tratar spm o pmdd.
EA201000464A1 (ru) Способ получения очищенного синтез-газа из синтез-газа, содержащего следовые количества примеси сернистых соединений, с помощью металлорганической структуры
BR112012030532A2 (pt) novos processos
BRPI0909695B8 (pt) processo de redução, processo de preparação de compostos e processo de preparação de nebivolol
WO2011071799A3 (en) Purification of bivalirudin
UY33181A (es) Derivados de oxazolopirimidina 2,5-sustituidos.
BRPI0612621B8 (pt) processo para produzir compostos químicos, e, composto
AR045836A1 (es) Proceso para preparar y purificar mesotriona
BRPI0508430A (pt) processo para a preparação de inibidores da triptase
NI200700226A (es) Recuperación de cci-779 a partir de soluciones madre
BRPI0418664A (pt) método para produzir um derivado de ácido (met) acrìlico
ES1063333Y (es) Estructura mejorada de soportes para seguidores solares
BR112012017307A2 (pt) composto oticamente ativo de prulifloxacina para tratamento de infecções e seu método de preparação